Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2024
Finding One Treatment for All Advanced EGFR-positive NSCLC-An Infinite TaskEdyta Maria Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu
Chinese Clinical Oncology|September 11, 2024
Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profileJens Benn Sørensen, Eric Santoni-Rugiu, Edyta Maria Urbanska
Journal of Cancer Research and Clinical Oncology|February 25, 2014
Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancerJan Nyrop Jakobsen, Eric Santoni-Rugiu, Jens Benn Sørensen
World Journal of Clinical Oncology|October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
European Clinical Respiratory Journal|November 3, 2025
Advances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelinesVasiliki Panou, Jens Benn Sørensen, Jesper Ravn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2013
Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancerJan Nyrop Jakobsen, Eric Santoni-Rugiu, Jesper Ravn, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 17, 2006
Progenitor cells in liver regeneration: molecular responses controlling their activation and expansionEric Santoni-Rugiu, Peter Jelnes, Snorri S Thorgeirsson, et al.
Anticancer Research|December 6, 2015
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural MesotheliomaZarah Glad Zimling, Eric Santoni-Rugiu, Cecilia Bech, et al.
Oncogene|November 9, 2004
Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CISKarl Agger, Eric Santoni-Rugiu, Christian Holmberg, et al.
Infectious Diseases (London, England)|January 28, 2015
Molecular imaging in Libman-Sacks endocarditisAnders Dahl, Bente K Schaadt, Eric Santoni-Rugiu, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2024
Finding One Treatment for All Advanced EGFR-positive NSCLC-An Infinite TaskEdyta Maria Urbanska, Jens Benn Sørensen, Eric Santoni-Rugiu
Chinese Clinical Oncology|September 11, 2024
Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profileJens Benn Sørensen, Eric Santoni-Rugiu, Edyta Maria Urbanska
Journal of Cancer Research and Clinical Oncology|February 25, 2014
Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancerJan Nyrop Jakobsen, Eric Santoni-Rugiu, Jens Benn Sørensen
World Journal of Clinical Oncology|October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaBenedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
European Clinical Respiratory Journal|November 3, 2025
Advances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelinesVasiliki Panou, Jens Benn Sørensen, Jesper Ravn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2013
Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancerJan Nyrop Jakobsen, Eric Santoni-Rugiu, Jesper Ravn, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 17, 2006
Progenitor cells in liver regeneration: molecular responses controlling their activation and expansionEric Santoni-Rugiu, Peter Jelnes, Snorri S Thorgeirsson, et al.
Anticancer Research|December 6, 2015
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural MesotheliomaZarah Glad Zimling, Eric Santoni-Rugiu, Cecilia Bech, et al.
Oncogene|November 9, 2004
Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CISKarl Agger, Eric Santoni-Rugiu, Christian Holmberg, et al.
Infectious Diseases (London, England)|January 28, 2015
Molecular imaging in Libman-Sacks endocarditisAnders Dahl, Bente K Schaadt, Eric Santoni-Rugiu, et al.
Pageof 10